Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1622 of 6351
-
New study tests kidney cancer combo in patients over 70
Disease control Recruiting nowThe goal of the study is to describe real-life use and exposition to nivolumab-cabozantinib among older patients with metastatic clear-cell renal cell cancer
Phase 4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Fish oil infusions tested to tame transplant complication
Disease control By invitation onlyStudy Title: A Study on the Effects and Mechanisms of Omega-3 Polyunsaturated Fatty Acids on Acute Graft-Versus-Host Disease (aGVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation Study Type: Open-label, randomized, single-center proof-of-concept clinical trial …
Phase 1/2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a simple blood test flag lung risk in preemies?
Knowledge-focused Recruiting nowIn adults and children low or high blood chloride levels are linked to the risk of death. The aim of this observational study is to determine whether there is a relationship between low or high blood chloride levels and the risk of death or long-term lung problems. We will also l…
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Robotic suits could help stroke patients regain their stride
Symptom relief Recruiting nowThe purpose of this research study is to evaluate and compare different robotic exoskeletons (RE) and identify which is most appropriate for gait training for each patient based off their specific needs. This will help guide clinicians in prescribing the appropriate RE for rehabi…
Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 13:04 UTC
-
Custom graft offers new hope for aneurysm patients
Disease control Recruiting nowThe purpose of this study is to assess the effects of a physician-modified endovascular graft (PMEG) for juxtarenal aortic aneurysms by collecting data on its performance. Participants in the study will undergo surgery to repair their juxtarenal aortic aneurysm using the PMEG dev…
Sponsor: Cali Johnson • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Gut feeling: could a probiotic ease depression in young brains?
Disease control Recruiting nowThis double-blind, placebo-controlled clinical trial will examine the effect of probiotic Visbiome on the brain and gut microbiome of individuals 15 to 24 years of age.
Early phase 1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can blood tests reveal how liver and bile duct cancers respond to treatment?
Knowledge-focused Recruiting nowThe BILLIONSTARS study is a prospective, single arm observational study inviting patients diagnosed with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) who are to be recommended locoregional intervention by surgery, ablation or transarterial chemoembolization and/or a…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New study tracks Ravulizumab's impact on daily life in myasthenia gravis
Disease control Recruiting nowThe Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for advanced cancers: first human trial of DXC008 begins
Disease control Recruiting nowThis is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor activity, the immunogenicity of DXC008 in patients with prostate cancer and other solid tumors such as Ewing …
Phase 1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug shows promise in cutting heavy drinking days
Disease control CompletedThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in the treatment of AUD in subjects with obesity or overweight. After signing the informed consent form, subjects will be screened and if eligible…
Phase 2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug trial aims to tame esophageal inflammation
Disease control Recruiting nowThis is a prospective, open-label drug study that will examine the effects of Zemaira (alpha-1 trypsin inhibitor) in patients with Eosinophilic Esophagitis.
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a common ADHD drug also treat depression?
Disease control Recruiting nowThe indication of attention-deficit/hyperactivity disorder (ADHD) to be examined often occurs with other psychiatric disorders, and the majority of adults with ADHD have at least one psychiatric comorbidity in their lives. Depression is one of the most common comorbidities in pat…
Phase 2 • Sponsor: Prof. Dr. Frank Behrens • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to control advanced colorectal cancer
Disease control Recruiting nowPhase II study of simultaneous infusion of levozolinate for injection and 5-FU as first-line treatment for advanced colorectal cancer
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
8 patients with β-thalassemia tracked for years after one-time cell therapy
Disease control By invitation onlyThis is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-01 (NCT06291961),No investigational drug product will be administered in the study.
Sponsor: CorrectSequence Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a phone app lower blood pressure in African-Americans? new study aims to find out.
Disease control Recruiting nowThe purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as co…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New headband could replace Needle-Based brain pressure monitoring
Diagnosis Recruiting nowThe clinical investigation aims to advance the Crainio device, designed for non-invasive intracranial pressure (ICP) monitoring. This feasibility study involves 54 participants over a 12-month period and seeks to collect cerebral photoplethysmogram signals alongside concurrent in…
Sponsor: Crainio Ltda • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New cocktail of cancer drugs shows promise in early trial
Disease control OngoingThis study is open to adults with head and neck cancer. The purpose of this study is to find out whether combining different study medicines makes tumors shrink in people with head and neck cancer. The tested medicines in this study are antibodies that act in different ways agai…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for CIDP: modified immune protein enters human testing
Disease control Recruiting nowCIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the bod…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for fabry patients: experimental drug enters human trials
Disease control Recruiting nowThis Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD.
Phase 1/2 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New stent aims to prevent stroke in patients with clogged brain arteries
Disease control Recruiting nowThis clinical trial is a prospective, multicenter, single-arm study. About 300 subjects undergoing rapamycin-eluting stent implantation will be enrolled based on the inclusion and exclusion criteria. The primary endpoint is the rate of any stroke or death within 1 month. Secondar…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC